M Wlasiuk
Overview
Explore the profile of M Wlasiuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bielawski K, Bernat A, Wlasiuk M, Falkiewicz B
Med Sci Monit
. 2002 Sep;
7 Suppl 1:197-201.
PMID: 12211719
Background: For HCV-RNA detection in liver tissue a generally accepted reference method has not been established yet. Therefore, we have developed a procedure of HCV-RNA extraction from liver tissue and...
2.
Bielawski K, Wlasiuk M, Truskolawska M, Falkiewicz B
Arch Med Res
. 2001 Feb;
31(5):532-5.
PMID: 11179591
Background: Hepatitis C virus (HCV) infection is one of the most prevalent infectious diseases in the world. In 1997, hepatitis C became a statutorily noticeable disease in Poland. Nevertheless, to...
3.
Slizien W, Michalik D, Wlasiuk M, Rutkowski B, Brylowska A
Przegl Lek
. 1995 Jan;
52(2):47-50.
PMID: 7784615
In 67 hemodialysis patients with high prevalence of HBV infection (64/67-95.5%) the occurrence of anti-HCV antibodies in second generation enzyme immunoassay was 61.2% (41/67). Among 40/67 (59.7%) patients with actually...
4.
ZIELINSKA W, Paszkiewicz J, Korczak A, Wlasiuk M, Zoltowska A, Szutowicz A, et al.
Arch Immunol Ther Exp (Warsz)
. 1993 Jan;
41(3-4):253-7.
PMID: 8129569
Following the widely accepted therapeutic standard of treatment of HCV infection with parenteral interferon alpha, and encouraged by the author's won good experience with orally administered natural human interferon alpha...
5.
ZIELINSKA W, Paszkiewicz J, Korczak A, Wlasiuk M, Zoltowska A, Szutowicz A, et al.
Arch Immunol Ther Exp (Warsz)
. 1993 Jan;
41(3-4):241-51.
PMID: 8129568
The therapy concept is based on a theory of the immunocorrective effect of orally administered natural human interferon alpha in low doses (leuHuIFN alpha (ldou)), manifolded by the logistic amplification...
6.
Smiatacz T, Wlasiuk M, Paszkiewicz J, ZIELINSKA W
Przegl Epidemiol
. 1991 Jan;
45(4):351-5.
PMID: 1841415
Among 46 i.v. drug abusers we revealed HBV infection in 36, presence of anti-HCV antibodies in 33, and HIV infection in 21. Prevalence of HBV markers and anti-HCV antibodies increased...
7.
ZIELINSKA W, Paszkiewicz J, Korczak A, Wlasiuk M, Zoltowska A, Szutowicz J, et al.
Przegl Epidemiol
. 1991 Jan;
45(4):325-30.
PMID: 1841411
The treatment conception was based on the theory of immunocorrective activity function of low doses of human interferon alpha (HuIFN alpha) multi-played by logistic amplifier system included in oral cavity....
8.
MICHALSKA Z, Radowska D, STOLARCZYK J, Wlasiuk M, Michalik D
Przegl Epidemiol
. 1991 Jan;
45(4):305-9.
PMID: 1841407
The total seroprevalence of HBsAg among pregnant women in Gdańsk region is 1.3%. Our examination was based on observation of 226 HBsAg chronic carrier pregnant women. The risk of infection...
9.
Pryzjemski J, Wlasiuk M, CHROSTOWSKA H
Przegl Lek
. 1976 Jan;
33(12):979-83.
PMID: 1013383
No abstract available.